Monthly Archives: July 2015

BAP1 Confirmed as a Good Focus of Mesothelioma Drug Research

BAP1 Confirmed as a Good Focus of Mesothelioma Drug Research

Scientists believe they now have compelling evidence to support theories that mutated BAP1 genes are where the action’s at when it comes to treating mesothelioma with advanced therapeutic agents. Researchers from Memorial Sloan Kettering Cancer Institute in New York City recently announced the results of an investigation confirming that there is a high prevalence of

Continue Reading →
Mesothelioma-afftecs-sex-hormone-levels

Sex Hormone Levels May Affect How Long You Survive Mesothelioma

Mesothelioma is no respecter of sex. Even though mesothelioma is seen as a men’s cancer, the fact is it also strikes women. But mesothelioma is not an equal-opportunity killer. As mesothelioma researchers have noted, women who develop mesothelioma tend to survive longer than men. This has led some mesothelioma experts to hypothesize that the better

Continue Reading →
Bevacizumab Increases Chemotherapy’s Potency Against Mesothelioma

Bevacizumab Increases Chemotherapy’s Potency Against Mesothelioma

The mesothelioma chemotherapy cocktail served most often by mesothelioma specialist doctors to mesothelioma patients like you is a blend of two agents: pemetrexed and cisplatin. Among mesothelioma specialist doctors, this is referred to as the gold standard of mesothelioma care. Pemetrexed together with cisplatin has held that status since 2003. The combination is also the

Continue Reading →
Why Mesothelioma Strikes Only Some Asbestos Exposure Victims

Why Mesothelioma Strikes Only Some Asbestos Exposure Victims

Just about everyone stricken by mesothelioma was at some point in the past exposed to asbestos. But not everyone exposed to asbestos develops mesothelioma. In fact, only about 10 percent of asbestos-exposure victims fall prey to mesothelioma. Scientists haven’t yet been able to satisfactorily explain why this is so. Increasingly, though, they believe it’s because

Continue Reading →
Mesothelioma Anti-Vasculature Agents Work Better Together

Mesothelioma Anti-Vasculature Agents Work Better Together

Two anti-angiogenic agents are better than one when it comes to disrupting mesothelioma tumor growth and slowing down the cancer’s progress. Researchers from Hyogo College of Medicine in Japan revealed last month that using multiple anti-angiogenic factors as gene therapy agents increases effectiveness against mesothelioma because this approach permits an attack on more than one

Continue Reading →
Mesothelioma Fears Appear After Crayons and Toys Test Positive for Asbestos

Mesothelioma Fears Appear After Crayons and Toys Test Positive for Asbestos

Better check to see which brand of crayons your grandkids are using when they color. Those crayons might contain asbestos. If so, then your grandkids are at risk of developing mesothelioma when they grow up. Time Magazine in early July reported that a consumer protection group recently tested crayons sold at a pair of national

Continue Reading →
Aspirin Might Be the Best Mesothelioma Drug

Aspirin Might Be the Best Mesothelioma Drug

If an international team of researchers is right, then one of the potentially best mesothelioma prevention and treatment drugs has been sitting in your medicine cabinet this entire time. It’s aspirin. Yes, you read that right. Ordinary aspirin. The little pill you’ve taken for years to get rid of headaches is apparently also good for

Continue Reading →
Signs Point to T Cells As Mesothelioma Treatment of the Future

Signs Point to T Cells As Mesothelioma Treatment of the Future

You’ve read a lot lately about T-cell therapies looking like they might be the wave of the future in mesothelioma treatment. They definitely are, according to the Massachusetts Institute of Technology (MIT). MIT took a long, hard look at T-cell therapy in the June 18 issue of its journal, MIT Technology Review. In the journal’s

Continue Reading →
Mystery Surrounds Near-Disappearance of Mesothelioma from Patient

Mystery Surrounds Near-Disappearance of Mesothelioma from Patient

Mesothelioma treatment researchers in Australia have a big mystery on their hands. It seems that for one mesothelioma patient in a clinical trial of microRNA delivered by nanocells the asbestos cancer has practically vanished from his body. The researchers conducting the clinical trial say the degree of improvement experienced by this mesothelioma patient is unheard

Continue Reading →